CAMBRIDGE, Mass. & LONDON, December 17, 2025--(BUSINESS WIRE)--Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific ...
Funding accelerates development of novel therapeutics to improve outcomes for patients with cancer Valink Therapeutics Inc. ("Valink"), a private biotechnology company developing next-generation ...
Under the terms of the agreement, Nona and Valink will combine Nona's industry-leading Harbour Mice ® fully human antibodies, including its heavy chain-only antibodies (HCAbs), with Valink's LiliumX™ ...
CAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--#ADC--Valink Therapeutics Inc. (“Valink”), a private biotechnology company developing next-generation oncology therapeutics with a focus on bispecific ...
Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results